Phenylcarbamates
Research News and Information

Sunday, November 22, 2009

O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.

2 Sep 2009 We previously demonstrated that the O-linked beta-N-acetylglucosamine (O-GlcNAc) posttranslational modification confers cardioprotection at least partially through mitochondrial-dependent mechanisms, but it remained unclear if O-GlcNAc signaling ... Read more...

Rivastigmine in Parkinson's disease dementia.

30 Jul 2009 Parkinson's disease has now evolved beyond what was considered to be a traditional motor disorder. It is being increasingly recognized that non-motor symptoms such as cognitive impairment, frank dementia, psychosis, depression, autonomic dysfunction ... Read more...

Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.

30 Jul 2009 OBJECTIVE: Evaluate the effect of sex and butyrylcholinesterase (BuChE) genotype on the incidence of Alzheimer's disease (AD), cognitive and functional decline, brain volume changes, and response to rivastigmine treatment in individuals with mild ... Read more...

Latest indexed articles for 'Phenylcarbamates'

These are the very latest articles for this heading:

• O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death. 2 Sep 2009
• Rivastigmine in Parkinson's disease dementia. 30 Jul 2009
• Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment. 30 Jul 2009
• Excessive O-GlcNAcylation of proteins suppresses spontaneous cardiogenesis in ES cells. 6 Jul 2009
• Development of an enzyme-linked immunosorbent assay for metolcarb residue analysis and investigation of matrix effects from different agricultural products. Jul 2009
• Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. 29 Jun 2009
• Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ. 29 Jun 2009
• Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance. 24 Jun 2009
• Composition analysis of positional isomers of phosphatidylinositol by high-performance liquid chromatography. 24 Jun 2009
• Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. 17 Jun 2009
• Artificial miniaturization causes eggs laid by crowd-reared (gregarious) desert locusts to produce green (solitarious) offspring in the desert locust, Schistocerca gregaria. 15 Jun 2009
• Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists. 15 Jun 2009
• Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine. 3 Jun 2009
• [Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?] 30 May 2009
• Drug-induced sialorrhoea and excessive saliva accumulation. 30 May 2009
• [Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)] 30 May 2009
• Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy. 16 May 2009
• Rivastigmine reduces tobacco craving in alcohol-dependent smokers. 16 May 2009
• Treatment of Alzheimer's disease in the long-term-care setting. 13 May 2009
• Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. 11 May 2009

See a longer list of these articles.

Technical information about 'Phenylcarbamates'

Definition: Phenyl esters of carbamic acid or of N-substituted carbamic acids. Structures are similar to PHENYLUREA COMPOUNDS with a carbamate in place of the urea.

Registry Number: 0

Descriptor UI: D048448

Alternative terms: Phenylcarbamates; Phenyl-Carbamates; Phenyl Carbamates;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.241.081.251.583;

History Note: 2005